Sulfonylurea
Top View
- Use of Exenatide and Liraglutide in Denmark: a Drug Utilization Study
- New Drug Evaluation: Albiglutide Month/Year of Review: January
- Scientific Presentations of Exenatide Data Show Significant
- Sulfonylurea Overdose in Children
- Liraglutide (Victoza)
- American Diabetes Association Treatment Algorithm for Type 2 Diabetes
- Sulfonylureas Rapidly Cross Phospholipid Bilayer Membranes by a Free-Diffusion Mechanism Frits Kamp,1 Nadeem Kizilbash,1 Barbara E
- What's Next After Metformin? Focus on Sulphonylurea: Add-On Or Combination Therapy
- BYETTA (Exenatide) Injection Hemodialysis and Kidney Transplantation
- Albiglutide (TANZEUM) Drug Monograph
- GLP-1 Receptor Agonists (Byetta /Victoza ) Step Therapy Criteria
- Antidiabetic Medication and Risk of Dementia in Patients with Type 2 Diabetes: a Nested Case–Control Study
- Comparative Safety and Efficacy of Glibenclamide in the Elderly
- Dipeptidyl Peptidase-4 Inhibitor Compared with Sulfonylurea in Combination with Metformin: Cardiovascular and Renal Outcomes In
- Rifamycins and Anti-Diabetic Agents: Drug-Drug Interactions
- Modern Sulfonylureas: Dangerous Matthew C
- Long-Acting Glucagon-Like Peptide 1 Receptor Agonists a Review of Their Efficacy and Tolerability
- Comparison of Insulin Degludec/Insulin